Literature DB >> 26604091

[Plasma exchange in treatment refractory septic shock : Presentation of a therapeutic add-on strategy].

S David1, M M Hoeper2, J T Kielstein3.   

Abstract

Sepsis is defined as a systemic inflammatory response of the body to an infection. Besides anti-infective drugs and removal of the site of infection, no specific therapeutics that target the overwhelming host response are available. Clinical researchers are currently evaluating the extracorporeal elimination of circulating cytokines. Modern adsorbing techniques have increasingly been used for this purpose allowing an unselective but highly effective removal of the vast majority of circulating cytokines but also fail to replace used protective factors in patients' plasma. Therapeutic plasma exchange (TPE) however might represent a novel method to remove pathologically elevated cytokines and simultaneously to replace protective plasmatic factors. Here we report the case of a septic shock patient treated with TPE and review the available literature with respect to TPE as an adjunctive therapy in sepsis.

Entities:  

Keywords:  Cytokines; Disseminated intravascular coagulation; Infection; Plasmapheresis; Systemic inflammatory response syndrome

Mesh:

Substances:

Year:  2015        PMID: 26604091     DOI: 10.1007/s00063-015-0117-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  11 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

2.  Haemodynamics in leptospirosis: effects of plasmapheresis and continuous venovenous haemofiltration.

Authors:  Tongprakob Siriwanij; Chuanpit Suttinont; Terapong Tantawichien; Sauwaluck Chusil; Talerngsak Kanjanabuch; Visith Sitprija
Journal:  Nephrology (Carlton)       Date:  2005-02       Impact factor: 2.506

3.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

4.  Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.

Authors:  J H Reeves; W W Butt; F Shann; J E Layton; A Stewart; P M Waring; J J Presneill
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

5.  Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.

Authors:  Rolf Busund; Vladimir Koukline; Uri Utrobin; Edvard Nedashkovsky
Journal:  Intensive Care Med       Date:  2002-07-23       Impact factor: 17.440

6.  Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support.

Authors:  Yu Kawai; Timothy T Cornell; Elaine G Cooley; Craig N Beckman; Paula K Baldridge; Theresa A Mottes; Kera E Luckritz; Kathryn S Plomaritas; J Michael Meade; Folafoluwa O Odetola; Yong Y Han; Neal B Blatt; Gail M Annich
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

7.  Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.

Authors:  Trung C Nguyen; Yong Y Han; Joseph E Kiss; Mark W Hall; Andrea Cortese Hassett; Ron Jaffe; Richard A Orr; Janine Janosky; Joseph A Carcillo
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

8.  A randomised controlled trial of plasma filtration in severe paediatric sepsis.

Authors:  Elliot J Long; Anna Taylor; Frank Shann; Gale Pearson; David Buckley; Warwick Butt
Journal:  Crit Care Resusc       Date:  2013-09       Impact factor: 2.159

Review 9.  The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Emily Rimmer; Brett L Houston; Anand Kumar; Ahmed M Abou-Setta; Carol Friesen; John C Marshall; Gail Rock; Alexis F Turgeon; Deborah J Cook; Donald S Houston; Ryan Zarychanski
Journal:  Crit Care       Date:  2014-12-20       Impact factor: 9.097

10.  Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients.

Authors:  Johannes Hadem; Carsten Hafer; Andrea S Schneider; Olaf Wiesner; Gernot Beutel; Thomas Fuehner; Tobias Welte; Marius M Hoeper; Jan T Kielstein
Journal:  BMC Anesthesiol       Date:  2014-04-07       Impact factor: 2.217

View more
  2 in total

1.  Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.

Authors:  Klaus Stahl; Philipp Wand; Christian Bode; Sascha David; Benjamin Seeliger; Pedro David Wendel-Garcia; Julius J Schmidt; Bernhard M W Schmidt; Andrea Sauer; Felix Lehmann; Ulrich Budde; Markus Busch; Olaf Wiesner; Tobias Welte; Hermann Haller; Heiner Wedemeyer; Christian Putensen; Marius M Hoeper
Journal:  Crit Care       Date:  2022-05-12       Impact factor: 19.334

2.  Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.

Authors:  Hannah Knaup; Klaus Stahl; Bernhard M W Schmidt; Temitayo O Idowu; Markus Busch; Olaf Wiesner; Tobias Welte; Hermann Haller; Jan T Kielstein; Marius M Hoeper; Sascha David
Journal:  Crit Care       Date:  2018-10-30       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.